rs186678728
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_015295.3(SMCHD1):c.2913+6C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000257 in 1,609,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_015295.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMCHD1 | NM_015295.3 | c.2913+6C>G | splice_region_variant, intron_variant | ENST00000320876.11 | NP_056110.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMCHD1 | ENST00000320876.11 | c.2913+6C>G | splice_region_variant, intron_variant | 5 | NM_015295.3 | ENSP00000326603.7 |
Frequencies
GnomAD3 genomes AF: 0.00141 AC: 215AN: 152094Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000304 AC: 74AN: 243712Hom.: 0 AF XY: 0.000272 AC XY: 36AN XY: 132324
GnomAD4 exome AF: 0.000135 AC: 196AN: 1456858Hom.: 0 Cov.: 30 AF XY: 0.000115 AC XY: 83AN XY: 724526
GnomAD4 genome AF: 0.00143 AC: 217AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.00136 AC XY: 101AN XY: 74416
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | May 05, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 04, 2018 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 28, 2021 | - - |
Facioscapulohumeral muscular dystrophy 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
SMCHD1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 10, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at